Advances in the treatment strategies of diabetic macular edema and the problems

VernacularTitle:糖尿病黄斑水肿治疗策略的变化与面临的问题
Author: Hong DAI ¹ ; Yingyi LU
Author Information

1. 北京医院眼科　国家老年医学中心，北京　100730
Keywords: Diabetic retinopathy; Macular edema; Angiogenesis inhibitors; Editorial
From: Chinese Journal of Ocular Fundus Diseases 2022;38(1):6-9
CountryChina
Language:Chinese
Abstract: Diabetic macular edema (DME) is one of the common causes of visual impairment. Anti-vascular endothelial growth factor (VEGF) has become the preferred therapy for DME because of significant visual improvement. Early and intensive anti-VEGF therapy combined with other individualized treatments are currently the main strategy for DME treatment. Considering the complexity of DME and limitations of anti-VEGF therapy, there are still many problems and difficulties in the treatment of DME. Optimizing treatment strategies, strengthening management of the clinical course and developing new drugs, could improve the efficacy and maintain the improvement of visual acuity and visual performance.